Sun Feb 14 03:14:24 SGT 2016  
    Botox® treatment, Singapore (SG)

Botox® treatment, Singapore (SG)


Botox® treatment, Singapore (SG) @singaporebotox_com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, Singapore. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.


Botox® treatment is with the original Allergan Botox® Cosmetic
  • The units differ for different brands.
  • Price quoted is for average ladies face, with average musculature.
  • Muscular men might require up to twice as much.
  • Minimum charge is for 10 units.

Botox® price. Average Botox® cost.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Horizontal forehead lines2816SG$240
Glabellar frown lines4520SG$300
Crow's feet4624SG$360

Jaw slimming / face slimming / Botox® jaw reduction / Botox® jaw slimming / Botox® face slimming price.

AreaIU/spotSpotsTotal IUPrice @ SG$15/IU
Jaw reduction8 to 12656SG$840

Botox® is one of the trade names for botulinum toxin, which is a protein produced by the bacterium clostridium botulinum.

Aesthetic services available:

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.


Latest News

Treatment of allergic rhinitis with intranasal infusion of botulinum toxin type A in mice
Thu, 11 Feb 2016 00:00:00 +0100 | Life Sciences
Conclusions Topical treatment with BTX-A efficiently and temporarily ameliorates AR symptoms. Intranasal infusion does not cause pain or bleeding, and the effects of a single infusion of BTX-A last for at least three weeks. This treatment might be a promising therapeutic strategy for the treatment of AR. (Source: Life Sciences)

Botulinum Toxin to Treat Neurogenic Bladder
Thu, 11 Feb 2016 00:00:00 +0100 | Seminars in Neurology
Semin Neurol 2016; 36: 005-009DOI: 10.1055/s-0035-1571216Alteration in neural control from suprapontine areas to the nerves innervating the bladder can lead to bladder dysfunction and the development of a neurogenic bladder (NGB). Patients with NGB often suffer from urinary incontinence, which can lead to adverse events such as urinary tract infections and decubiti, in addition to creating a large care burden for family members or healthcare providers and significantly impairing patient quality of life. The common failure of anticholinergic medications has spurned the development of second-line treatments, including the use of botulinum toxin. OnabotulinumtoxinA (onaBoNT-A; BOTOX, Allergan, Inc.) was approved by the U.S. Food and Drug Administration (FDA) in 2011 to treat neurogenic detrus...

The Use of Botulinum Toxin in the Management of Headache Disorders
Thu, 11 Feb 2016 00:00:00 +0100 | Seminars in Neurology
Semin Neurol 2016; 36: 092-098DOI: 10.1055/s-0036-1571443Headache disorders can be further classified as episodic (< 15 headache days per month) or chronic (≥15 headache days per month for more than 3 months). Chronic migraine (CM) requires that headaches occur on 15 or more days a month for more than 3 months. These headaches must be migraines on at least 8 days per month. There are seven botulinum toxin (BoNT) serotypes (A1, A2, A3, B, C1, D, E, F, and G). All serotypes inhibit acetylcholine release, although their intracellular target proteins, physiochemical characteristics, and potencies are different. Its mechanism of action in pain is being investigated. Botulinum toxin type A (BoNT-A) has been the most widely studied serotype for therapeutic purposes. A major clinical advantag...

Abdominal Cramping as a symptom of benign fasciculation syndrome with an excellent response to botulinum toxin
Wed, 10 Feb 2016 00:00:00 +0100 | Basal Ganglia
Conclusion This patient shows that in cases of BFS, localized cramps can be successfully treated with low doses of botulinum toxin. (Source: Basal Ganglia)

Outcomes of Botulinum Toxin Type A Injection Followed by Rehabilitation in Cases of Cerebral Palsy With Upper Extremity Involvement
Tue, 09 Feb 2016 00:00:00 +0100 | Journal of Child Neurology
We evaluated the efficiency of botulinum toxin type A injection followed by a rehabilitation program including individual therapy, group therapy, and occupational therapy in cases of cerebral palsy with upper extremity involvement. A total of 29 injections were performed on 25 patients, and the patients were placed on rehabilitation program. At 3-month and 6-month assessments, there was a significant improvement in lateral grip strength, 9 Hole Peg test, Upper Limb Physician’s Rating Scale and pediatric functional independence measure total scores. There were significant decreases in active range of motion in elbow extension, supination, and wrist extension, and Modified Ashworth Scale in elbow flexion, elbow pronation, and wrist flexion at 6-week, 3-month, and 6-month assessments. C...

Metro Denver Pain Management Now Offering Over Ten Effective Migraine...
Mon, 08 Feb 2016 19:19:01 +0100 | PRWeb: Medical Pharmaceuticals
The Board Certified providers at Metro Denver Pain Management are now offering over ten effective migraine headache treatments. New options include Botox injections and occipital blocks, which have...(PRWeb February 08, 2016)Read the full story at (Source: PRWeb: Medical Pharmaceuticals)

Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Mon, 08 Feb 2016 11:54:04 +0100 | Yonsei Medical Journal
CONCLUSION: Using a computerized gait analysis and foot scan, this study revealed significant benefits of BoNT-A injection into the GCM and TP muscles for dynamic equinovarus foot in children with spastic CP.

Intravesical electromotive botulinum toxin type A administration for management of concomitant neuropathic bowel and bladder dysfunction in children
Thu, 04 Feb 2016 00:00:00 +0100 | International Journal of Colorectal Disease
(Source: International Journal of Colorectal Disease)

Botulinum Toxin Type A for Relief of Intractable Pain After Face and Brow-Lift Surgery
Mon, 01 Feb 2016 06:00:00 +0100 | Dermatologic Surgery
No abstract available (Source: Dermatologic Surgery)

DYSPORT (Botulinum Toxin Type A) Injection, Powder, Lyophilized, For Solution [Galderma Laboratories, L.P.]
Wed, 27 Jan 2016 05:00:00 +0100 | DailyMed Drug Label Updates
Updated Date: Jan 27, 2016 EST (Source: DailyMed Drug Label Updates)